Atlas Genetics Ltd - Product Pipeline Analysis, 2017 Update
"Atlas
Genetics Ltd - Product Pipeline Analysis, 2017 Update"
The Report covers current Industries Trends, Worldwide Analysis,
Global Forecast, Review, Share, Size, Growth, Effect.
Description-
Summary
Atlas Genetics Ltd (Atlas Genetics) is an in vitro diagnostics company that offers decentralised, near-patient and point of care testing services. The company develops and offers diagnostic platforms such as io system and callisto system. Its io system is a diagnostic instrument and disposable cartridge system, which is designed for POC testing services to provide accurate solution to screening for the presence of STIs and HAIs. The company's products and solutions are used in the diagnosis of sexually transmitted infections, neonatal sepsis, and hospital acquired infection. It serves clinicians and other healthcare professionals. The company opreates through its offices in the US and the UK. Atlas Genetics is headquartered in Trowbridge, the UK.
Atlas Genetics Ltd (Atlas Genetics) is an in vitro diagnostics company that offers decentralised, near-patient and point of care testing services. The company develops and offers diagnostic platforms such as io system and callisto system. Its io system is a diagnostic instrument and disposable cartridge system, which is designed for POC testing services to provide accurate solution to screening for the presence of STIs and HAIs. The company's products and solutions are used in the diagnosis of sexually transmitted infections, neonatal sepsis, and hospital acquired infection. It serves clinicians and other healthcare professionals. The company opreates through its offices in the US and the UK. Atlas Genetics is headquartered in Trowbridge, the UK.
Get
Sample
Report
With TOC @
http://www.researchmoz.us/enquiry.php?type=S&repid=1067297
This
report is a source for data, analysis, and actionable intelligence on
the companys portfolio of pipeline products. The report provides key
information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Atlas Genetics Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Atlas Genetics Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table
of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Atlas Genetics Ltd Company Overview 5
Atlas Genetics Ltd Company Snapshot 5
Atlas Genetics Ltd Pipeline Products and Ongoing Clinical Trials Overview 5
Atlas Genetics Ltd Pipeline Analysis Overview 8
Atlas Genetics Ltd - Key Facts 8
Atlas Genetics Ltd - Major Products and Services 9
Atlas Genetics Ltd Pipeline Products by Development Stage 10
Atlas Genetics Ltd Pipeline Products Overview 12
Atlas io System - Bacterial Identification And Antibiotic Resistance 12
Atlas io System - Bacterial Identification And Antibiotic Resistance Product Overview 12
Atlas io System - Bacterial Meningitis Assay 13
Atlas io System - Bacterial Meningitis Assay Product Overview 13
Atlas io System - CT/NG Test 14
Atlas io System - CT/NG Test Product Overview 14
Atlas io System - Dual MRSA/MSSA Assay 15
Atlas io System - Dual MRSA/MSSA Assay Product Overview 15
Atlas io System - Group A Streptococcus Assay 16
Atlas io System - Group A Streptococcus Assay Product Overview 16
Atlas io System - Group B Streptococcus Assay 17
Atlas io System - Group B Streptococcus Assay Product Overview 17
Atlas io System - HPV Assay 18
Atlas io System - HPV Assay Product Overview 18
Atlas io System - HSV Assay 19
Atlas io System - HSV Assay Product Overview 19
Atlas io System - MRSA Assay 20
Atlas io System - MRSA Assay Product Overview 20
Atlas io System - Norwalk Viruses Assay 21
Atlas io System - Norwalk Viruses Assay Product Overview 21
Atlas io System - Sepsis 22
Atlas io System - Sepsis Product Overview 22
Atlas io System - Trichomonas Vaginalis 23
Atlas io System - Trichomonas Vaginalis Product Overview 23
Atlas Syphilis Anti-Treponemal Antibody Test (IgG & IgM) 24
Atlas Syphilis Anti-Treponemal Antibody Test (IgG & IgM) Product Overview 24
Atlas Genetics Ltd - Key Competitors 25
Atlas Genetics Ltd - Key Employees 26
Atlas Genetics Ltd - Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Atlas Genetics Ltd, Recent Developments 28
Jan 05, 2017: Atlas Genetics announces positive results from the first US Chlamydia trachomatis beta study 28
Jun 02, 2016: ONeill anti-microbial resistance report highlights the necessity for the Atlas io test platform for infectious diseases 28
Feb 16, 2016: New test detects chlamydia in 30 minutes 29
Feb 08, 2016: Atlas Genetics Gains CE Approval for First Product 30
Nov 16, 2015: Atlas Genetics appoints Keith Stauffer as VP Sales & Marketing 30
Sep 14, 2015: Atlas Genetics Grant of Key US Patent 30
Jun 11, 2015: Atlas Participates in 1.5m Grant Funding Award 31
Jun 17, 2014: Atlas completes development of io Cartridge and establishes manufacturing capability at Bespak UK 31
Jan 16, 2014: Atlas Completes Development of io Reader, a Point-of-Care Device for Rapid Detection of Infectious Diseases 32
Nov 27, 2013: Atlas Appoints David Whitaker as Operations Director 32
Appendix 33
Methodology 33
About GlobalData 35
Table of Contents 2
List of Tables 4
List of Figures 4
Atlas Genetics Ltd Company Overview 5
Atlas Genetics Ltd Company Snapshot 5
Atlas Genetics Ltd Pipeline Products and Ongoing Clinical Trials Overview 5
Atlas Genetics Ltd Pipeline Analysis Overview 8
Atlas Genetics Ltd - Key Facts 8
Atlas Genetics Ltd - Major Products and Services 9
Atlas Genetics Ltd Pipeline Products by Development Stage 10
Atlas Genetics Ltd Pipeline Products Overview 12
Atlas io System - Bacterial Identification And Antibiotic Resistance 12
Atlas io System - Bacterial Identification And Antibiotic Resistance Product Overview 12
Atlas io System - Bacterial Meningitis Assay 13
Atlas io System - Bacterial Meningitis Assay Product Overview 13
Atlas io System - CT/NG Test 14
Atlas io System - CT/NG Test Product Overview 14
Atlas io System - Dual MRSA/MSSA Assay 15
Atlas io System - Dual MRSA/MSSA Assay Product Overview 15
Atlas io System - Group A Streptococcus Assay 16
Atlas io System - Group A Streptococcus Assay Product Overview 16
Atlas io System - Group B Streptococcus Assay 17
Atlas io System - Group B Streptococcus Assay Product Overview 17
Atlas io System - HPV Assay 18
Atlas io System - HPV Assay Product Overview 18
Atlas io System - HSV Assay 19
Atlas io System - HSV Assay Product Overview 19
Atlas io System - MRSA Assay 20
Atlas io System - MRSA Assay Product Overview 20
Atlas io System - Norwalk Viruses Assay 21
Atlas io System - Norwalk Viruses Assay Product Overview 21
Atlas io System - Sepsis 22
Atlas io System - Sepsis Product Overview 22
Atlas io System - Trichomonas Vaginalis 23
Atlas io System - Trichomonas Vaginalis Product Overview 23
Atlas Syphilis Anti-Treponemal Antibody Test (IgG & IgM) 24
Atlas Syphilis Anti-Treponemal Antibody Test (IgG & IgM) Product Overview 24
Atlas Genetics Ltd - Key Competitors 25
Atlas Genetics Ltd - Key Employees 26
Atlas Genetics Ltd - Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Atlas Genetics Ltd, Recent Developments 28
Jan 05, 2017: Atlas Genetics announces positive results from the first US Chlamydia trachomatis beta study 28
Jun 02, 2016: ONeill anti-microbial resistance report highlights the necessity for the Atlas io test platform for infectious diseases 28
Feb 16, 2016: New test detects chlamydia in 30 minutes 29
Feb 08, 2016: Atlas Genetics Gains CE Approval for First Product 30
Nov 16, 2015: Atlas Genetics appoints Keith Stauffer as VP Sales & Marketing 30
Sep 14, 2015: Atlas Genetics Grant of Key US Patent 30
Jun 11, 2015: Atlas Participates in 1.5m Grant Funding Award 31
Jun 17, 2014: Atlas completes development of io Cartridge and establishes manufacturing capability at Bespak UK 31
Jan 16, 2014: Atlas Completes Development of io Reader, a Point-of-Care Device for Rapid Detection of Infectious Diseases 32
Nov 27, 2013: Atlas Appoints David Whitaker as Operations Director 32
Appendix 33
Methodology 33
About GlobalData 35
Comments
Post a Comment